ArticleInternational journal of general medicine2025
Impact of Transfer Timing on Day-6 Blastocyst Pregnancy Outcomes in HRT Cycles of 2021-2024.
Article in International journal of general medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: The achievement of a healthy live birth from a singleton pregnancy has become the primary objective of modern Assisted Reproductive Technology (ART). Consequently, the effective utilization of a single blastocyst is of paramount importance. However, the optimal approach to improving clinical pregnancy rates for Day-6 (D6) blastocysts in the hormonal replacement therapy frozen embryo transfer (HRT-FET) cycle remains unclear. Methods: This study retrospectively analyzed 990 D6 single blastocyst HRT-FET cycles conducted at the Reproductive Medicine Center of Nanjing Drum tower Hospital from January 2021 to April 2024. Patients were categorized based on the timing of embryo transfer (on the 6th or 7th day of progesterone administration), and both univariate and multivariate regression analyses were employed to assess the impact of transfer timing on clinical pregnancy outcomes. Results: The results revealed no significant differences in baseline characteristics or treatment cycle parameters between the two groups based on transfer timing. Univariate analysis identified several factors, including the age of both partners, infertility etiology, anti-Müllerian hormone (AMH) levels, antral follicle count (AFC), and the number of prior ART cycles, which may influence clinical pregnancy outcomes. After adjusting for these variables, multivariate regression analysis indicated that the timing of endometrial preparation for D6 single blastocyst transfer did not significantly affect clinical pregnancy rates. Conclusion: In conclusion, our retrospective data suggest that transferring single D6 blastocysts on either the sixth or seventh day of progesterone administration in HRT-FET cycles yields comparable clinical pregnancy outcomes. Until further prospective evidence emerges, our findings do not support routine delay of D6 blastocyst transfers in HRT cycles.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.